中东和北非地区淋巴瘤 NCCN 指南的修改和实施。
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region.
机构信息
Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
出版信息
J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S29-35. doi: 10.6004/jnccn.2010.0122.
In the Middle East and North Africa (MENA) region, cancer has many epidemiologic and clinical features that are different from those in the rest of the world. Additionally, the region has a relatively young population and large disparities in the availability of resources at diagnostic and treatment levels. A critical need exists for regional guidelines on cancer care, including those for lymphoid malignancies. A panel of lymphoma experts from MENA reviewed the 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non-Hodgkin's Lymphoma and Hodgkin Lymphoma and suggested modifications for the region that were discussed with the United States NCCN Lymphoma Panels. This article presents the consensus recommendations.
在中东和北非（MENA）地区，癌症具有许多与世界其他地区不同的流行病学和临床特征。此外，该地区的资源在诊断和治疗水平上存在较大差异，且人口相对年轻。因此，迫切需要制定癌症治疗的区域指南，包括淋巴恶性肿瘤的指南。来自 MENA 的一组淋巴瘤专家审查了 NCCN 临床实践肿瘤学指南（NCCN 指南）关于非霍奇金淋巴瘤和霍奇金淋巴瘤的 2009 年版本，并提出了针对该地区的修改建议，这些建议在美国 NCCN 淋巴瘤专家组进行了讨论。本文介绍了共识建议。
Zotero 插件